AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2020
Historique:
received: 20 06 2019
accepted: 15 08 2019
entrez: 28 8 2019
pubmed: 28 8 2019
medline: 25 11 2020
Statut: ppublish

Résumé

New approaches, like the Adverse Outcome Pathway (AOP) framework, have been developed to describe how chemicals cause toxicity by linking in vitro assays to adverse health outcomes. However, approaches, tools and resources for development of AOPs have not been well described. Here we review information resources for AOP development and define a streamlined process for linking a chemical to an existing AOP. We propose a four step process to facilitate AOP development: link the uncharacterized chemical directly to Molecular Initiating Events, Key Events, or Adverse Outcomes; identify analogs with toxicological information for the uncharacterized chemical; link the characterized chemical (initial chemical if characterized, a characterized analog if initial chemical is not) to Molecular Initiating Events, Key Events, or Adverse Outcomes; and identify AOPs that contain the Molecular Initiating Events, Key Events, or Adverse Outcomes that were found in Steps 1 and 3. The process and library of informational resources proposed and tested here served as the foundation for an informational online tool (AOPERA) that helps practitioners identify their current-state knowledge gaps, navigate the four-step process, and connect to relevant resources. AOPERA can be found at https://igbb.github.io/AOPERA_HTML. Additionally, we anticipate that by simplifying and standardizing the process of linking a chemical to a known AOP, we will lower the barrier to entry for this objective and increase its accessibility to new practitioners. In turn, this may increase the demand for new or improved AOPs to which practitioners can link chemicals, thereby contributing to the expansion of the library of known AOPs.

Identifiants

pubmed: 31453632
doi: 10.14573/altex.1906201
doi:

Substances chimiques

Hazardous Substances 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-74

Auteurs

Taylor E Rycroft (TE)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Christy M Foran (CM)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Adam Thrash (A)

Institute for Genomics, Biocomputing & Biotechnology, Mississippi State University, Starkville, MS, USA.

Jeffrey C Cegan (JC)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Robert Zollinger (R)

Contractor to the Environmental Laboratory, U.S. Army Engineer Research and Development Center, Concord, MA, USA.

Igor Linkov (I)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Edward J Perkins (EJ)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Natàlia Garcia-Reyero (N)

Environmental Laboratory, U.S. Army Engineer Research and Development Center, Vicksburg, MS, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH